Bringing the Oncology Community Together

Leukemia

Latest Leukemia Articles View more >>
FDA Approves First-Line Ofatumumab for Fludarabine-Ineligble Patients With CLL
FDA Approves First-Line Ofatumumab for Fludarabine-Ineligble Patients With CLL
The FDA has approved ofatumumab plus chlorambucil for previously untreated patients with chronic lymphocytic leukemia who are considered inappropriate for treatment with fludarabine therapy.
Hitting the Target: How Druker’s Persistence Helped Launch a New Mode of Attack
Hitting the Target: How Druker’s Persistence Helped Launch a New Mode of Attack
Take a prognosis of three years, multiply it by 10, and what do you get? A staggering improvement in the survival of patients with chronic myeloid leukemia (CML), and a crucial steppingstone on the road to the targeted treatment of cancer.
Targeted Therapies Usher in a New Era in CLL: Wierda Discusses Key Facets of Emerging Agents
Targeted Therapies Usher in a New Era in CLL: Wierda Discusses Key Facets of Emerging Agents
The approval of the first small-molecule, targeted therapy for patients with chronic lymphocytic leukemia (CLL) launches a new era that promises to transform management of the disease, yet significant challenges in translating research advances into improvements in long-term outcomes remain
Younger Patients With ALL Could Bypass a Transplant
Younger Patients With ALL Could Bypass a Transplant
The role of allogeneic transplant in the treatment of adult patients with acute lymphoblastic leukemia (ALL) is evolving as a result of new studies providing evidence of the efficacy of an improved chemotherapy regimen
Obinutuzumab Gains Role in CLL Guidelines
Obinutuzumab Gains Role in CLL Guidelines
Amid advances in targeted therapies for patients with chronic lymphocytic leukemia (CLL), researchers also have been making strides in the realm of chemoimmunotherapy regimens for the disease.
Partner Spotlight

Predicting Treatment Outcomes in Older Adults With AML

Heidi D. Klepin, MD, MS, from Wake Forest Baptist Health, writes about measurable patient characteristics that predict better outcomes for older adult with AML.

Read more >>>
Publications
External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc
OncLive Resources

Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives


About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright OncLive 2006-2014
Intellisphere, LLC. All Rights Reserved.